Construction of adenovirus vectors through Cre-lox recombination

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 1842-1849

  Hardy, Stephen ^a   Kitamura, Marina ^a   Harris Stansil, Tonja ^a   Dai, Yumin ^a   Phipps, M Lisa ^a  

^a CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINASE; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL LINE; GENE TRANSFER; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0031055468     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.1842-1849.1997     Document Type: Article

References (30)

1. Anton, M., and F. L. Graham. 1995. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression. J. Virol. 69:4600-4606.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology, vol. 1. John Wiley & Sons, New York, N.Y.
3. Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91:8802-8806.
4. Bett, A. J., L. Prevec, and F. L. Graham. 1993. Packaging capacity and stability of human adenovirus type 5 vector. J. Virol. 67:5911-5921.
5. Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810.
6. Chinnadurai, G., S. Chinnadurai, and J. Brusca. 1979. Physical mapping of a large-plaque mutation of adenovirus type 2. J. Virol. 32:623-628.
7. Fisher, K. J., H. Choi, J. Burda, S. Chen, and J. M. Wilson. 1996. Recombinant adenoviruses deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11-22.
8. Dai, Y., E. M. Schwarz, D. Gu, W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
9. Gage, P. J., B. Sauer, M. Levine, and J. C. Glorioso. 1992. A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J. Virol. 66:5509-5515.
10. Grable, M., and P. Hearing. 1990. Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J. Virol. 64:2047-2056.
11. Grable, M., and P. Hearing. 1992. cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J. Virol. 66:723-731.
12. Graham, F. L., J. Smiley, W. C. Russel, and R. Narin. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
13. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
14. Hardy, S. F., M. Lewendowski, G. Martin, and Z. W. Hall. Unpublished data.
15. Hay, R. T., N. D. Stow, and I. M. McDougall. 1984. Replication of adenovirus mini-chromosomes. J. Mol. Biol. 175:493-510.
16. Hearing, P., R. J. Samulski, W. L. Wishart, and T. Shenk. 1987. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J. Virol. 61:2555-2558.
17. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
18. Imler, J. L., C. Chartier, A. Dieterle, D. Dreyer, M. Mehtali, and A. Pavirani. 1995. An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther. 2:263-268.
19. Keiner, G., F. Spencer, S. Tugendriech, C. Connelly, and P. Hieter. 1994. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc. Natl. Acad. Sci. USA 91:6186-6190.
20. Kochanek, S., P. R. Clemens, K. Mitani, H. H. Chen, S. Chan, and C. T. Caskey. 1996. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galctosidase. Proc. Natl. Acad. Sci. USA 93:5731-5736.
21. McGrory, W. J., D. S. Basutista, and F. L. Graham. 1988. Short Communications: a simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163:614-617.
22. Miyake, S., M. Makimura, Y. Kanegae, S. Harada, Y. Sato, K. Takamori, C. Tokuda, and I. Saito. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing full-length virus genome. Proc. Natl. Acad. Sci. USA 93:1320-1324.
23. Nolan, G. P., S. Fiering, J.-F. Nicolas, and L. A. Herzenberg. 1988. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. USA 85:2603-2607.
24. Sauer, B. 1987. Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 7:2087-2096.
25. Shenk, T. 1996. Adenoviridae: the viruses and their replication, p. 2111-2148. In B. N. Fields et al. (ed.), Fields virology. Raven Press, New York, N.Y.
26. Stow, N. D. 1981. Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. J. Virol. 37:171-180.
27. Tamanoi, F., and B. W. Stillman. 1982. Function of adenovirus terminal protein in the initiation of DNA replication. Proc. Natl. Acad. Sci. USA 79:2221-2225.
28. Thimmappaya, B., C. Weinberger, R. J. Schnider, and T. Shenk. 1982. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543-551.
29. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
30. Young, C. S. H., T. Shenk, and H. S. Ginsberg. 1984. The genetic system, p. 125-172. In H. S. Ginsberg (ed.). The adenoviruses. Plenum Press, New York, N.Y.